Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph J Muldoon

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Nature Biotechnology|October 21, 2025
Integrated epigenetic and genetic programming of primary human T cellsLaine Goudy, Alvin Ha, Ashir A Borah, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionVincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
Immunity|February 5, 2025
In vivo engineering of murine T cells using the evolved adeno-associated virus variant Ark313William A Nyberg, Charlotte H Wang, Jonathan Ark, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple MyelomaAlexis Talbot, Ke Li, Jae Hyun J Lee, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Nature Biotechnology|October 21, 2025
Integrated epigenetic and genetic programming of primary human T cellsLaine Goudy, Alvin Ha, Ashir A Borah, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionVincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
Immunity|February 5, 2025
In vivo engineering of murine T cells using the evolved adeno-associated virus variant Ark313William A Nyberg, Charlotte H Wang, Jonathan Ark, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple MyelomaAlexis Talbot, Ke Li, Jae Hyun J Lee, et al.
Pageof 3